Primary myelofibrosis

Changed by Mostafa Elfeky, 12 Mar 2020

Updates to Article Attributes

Body was changed:

Primary myelofibrosis is a myeloproliferative neoplasm in which there is the replacement of bone marrow with collagenous connective tissue and progressive fibrosis. It is characterised by:

Epidemiology

It usually affects the middle-aged to elderly, with a mean age of 60 years 6. The estimated prevalence is ~1:100,000.

Pathology

It is considered a chronic BCR-ABL1 (breakpoint cluster region-Abelson murine leukemia viral oncogene homologue 1)-negative myeloproliferative disorder 11.

Non-neoplastic fibroblasts produce collagen, which replaces normal bone marrow elements. This bone marrow fibrosis is a result of an inappropriate release of PDGF and TGF-ß from neoplastic megakaryocytes 8.​

Radiographic features

Most radiological features are a result of extramedullary haematopoiesis and seen in many systems.

General
Musculoskeletal
  • osteosclerosis
    • diffuse pattern
    • no bony architectural distortion
    • typical distribution:
      • axial skeleton
      • ribs
      • proximal humerus and femur
    • bone scan may give "superscan" appearance
Abdominal
Cardiovascular

Treatment and prognosis

Prognosis is poor, with slow progression and death usually within 2-3 years. It can also transform into acute myeloid leukaemia in a small number of patients 10.

Complications
  • gout: from hyperuricaemia due to increased haematopoietic turnover
  • splenic rupture (rare) 9
  • bleeding from thrombocytopenia (see case 8)

Differential diagnosis

General differential considerations include:

See also

  • -<p><strong>Primary myelofibrosis</strong> is a <a title="Myeloproliferative neoplasm" href="/articles/myeloproliferative-neoplasm-1">myeloproliferative neoplasm</a> in which there is the replacement of <a href="/articles/bone-marrow">bone marrow</a> with collagenous connective tissue and progressive fibrosis. It is characterised by:</p><ul>
  • +<p><strong>Primary myelofibrosis</strong> is a <a href="/articles/myeloproliferative-neoplasm-1">myeloproliferative neoplasm</a> in which there is the replacement of <a href="/articles/bone-marrow">bone marrow</a> with collagenous connective tissue and progressive fibrosis. It is characterised by:</p><ul>
  • -<li>bone scan may give "<a href="/articles/superscan">superscan</a>" appearance</li>
  • +<li>
  • +<a title="Bone scan" href="/articles/bone-scan">bone scan</a> may give "<a href="/articles/superscan">superscan</a>" appearance</li>
  • -<li>from portal flow obstruction from the sinusoidal haematopoetic proliferation</li>
  • +<li>from portal flow obstruction from the sinusoidal haematopoietic proliferation</li>
  • -</li></ul><h4>Treatment and prognosis</h4><p>Prognosis is poor, with slow progression and death usually within 2-3 years. It can also transform into acute myeloid leukaemia in a small number of patients <sup>10</sup>.</p><h5>Complications</h5><ul>
  • +</li></ul><h4>Treatment and prognosis</h4><p>Prognosis is poor, with slow progression and death usually within 2-3 years. It can also transform into <a title="Acute myeloid leukaemia" href="/articles/acute-myeloid-leukaemia">acute myeloid leukaemia</a> in a small number of patients <sup>10</sup>.</p><h5>Complications</h5><ul>
  • -</ul><h4>See also</h4><ul><li><a title="WHO classification of tumours of haematopoietic and lymphoid tissues" href="/articles/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-1">WHO classification of tumours of haematopoietic and lymphoid tissues</a></li></ul>
  • +</ul><h4>See also</h4><ul><li><a href="/articles/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-1">WHO classification of tumours of haematopoietic and lymphoid tissues</a></li></ul>
Images Changes:

Image 10 X-ray (Fronal pelvis radiograph) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.